One-carbon is receiving a seed investment

by admin
september 10, 2021

One-carbon is receiving a seed investment from its founders to strengthen the financial situation and secure continuous pre-clinical development of MTHFD2 inhibitors.

Rekommenderade artiklar

We are presenting our novel MTHFD1/2 inhibitor at the DDR inhibitor summit

We are presenting our data at the DDR inhibitor summit,

One-carbon Therapeutics receives US patent

We are happy to announce that on the 22nd of

We are presenting at Bio-Europe 2022, October 24–26, Leipzig, Germany

We look forward to meeting you in person and sharing

Menu bar